NYSE · Analyst Forecast

Bristol-Myers Squibb Company (BMY) Stock Forecast & Price Target

$63.04 NYSE: BMY Market Cap $128.86B

Price as of Nov 16, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Bristol-Myers Squibb Company (BMY), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Bristol-Myers Squibb Company, analysts forecast revenue falling from $47.99B in 2025 to $37.09B in 2030; the average estimate for 2030 earnings per share is $4.93; with published estimates ranging from $4.72 to $5.14; 23 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$63.04
Consensus targetThe average of the price targets analysts have published.$66.08
Median targetThe middle target, less affected by a single outlier.$65.00
Highest targetThe most optimistic published target.$78.00
Lowest targetThe most pessimistic published target.$41.00
Difference from priceHow far the consensus target sits from today’s price.+4.8%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$47.74B$47.99B$48.19B18
2026$49.70B$50.17B$50.62B19
2027$47.49B$48.83B$50.77B20
2028$35.31B$40.38B$45.65B23
2029$36.01B$37.25B$38.47B11
2030$35.86B$37.09B$38.31B11

Earnings per share forecast

YearLowAverageHighAnalysts
2025$5.94$6.11$6.5118
2026$6.16$6.44$6.8419
2027$6.16$6.70$7.2820
2028$3.99$5.30$6.5723
2029$4.64$4.85$5.0511
2030$4.72$4.93$5.1411

Bristol-Myers Squibb Company (BMY) forecast — frequently asked questions

What is the analyst price target for Bristol-Myers Squibb Company?

Analysts covering Bristol-Myers Squibb Company (BMY) have a consensus price target of $66.08, 4.8% above the current price of $63.04. Published targets range from $41.00 to $78.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Bristol-Myers Squibb Company's earnings?

The average analyst estimate for Bristol-Myers Squibb Company (BMY) earnings per share in 2030 is 4.93, with individual estimates between 4.72 and 5.14.

How much revenue is Bristol-Myers Squibb Company expected to make?

Analysts forecast Bristol-Myers Squibb Company (BMY) revenue of $37.09B in 2030, based on 11 published estimates.

How many analysts cover BMY?

23 analysts contribute estimates for Bristol-Myers Squibb Company (BMY). Thin coverage makes an average less reliable.

Analyst forecasts for other Drug Manufacturers - General stocks

LLY forecastJNJ forecastABBV forecastMRK forecastNVS forecastAZN forecastAMGN forecastGILD forecastNVO forecastPFE forecastAll Drug Manufacturers - General stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.